U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. BE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. ROIV

Go back to U.S. Food and Drug Administration Approves Longeveron’s Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition
LOGICVISION (NASDAQ: LGVN) Delayed: 6.81 --0 (-0%)
Previous Close $6.81    52 Week High $1.62 
Open $6.81    52 Week Low $0.35 
Day High $6.81    P/E N/A 
Day Low $6.81    EPS $-0.17 
Volume 901